Reaction Details Report a problem with these data
Target
Fibroblast growth factor receptor 2
Ligand
BDBM287085
Substrate
n/a
Meas. Tech.
Inhibition of FGFR2-Dependent Cell Growth
IC50
27.4±n/a nM
Citation
 Verner, E; Brameld, KA Quinolone derivatives as fibroblast growth factor receptor inhibitors US Patent  US10294223 Publication Date 5/21/2019 
Target
Name:
Fibroblast growth factor receptor 2
Synonyms:
BEK | CD_antigen=CD332 | FGFR-2 | FGFR-2 Tyrosine Kinase | FGFR2 | FGFR2_HUMAN | Fibroblast growth factor receptor 2 (FGFR2) | Fibroblast growth factor receptor 2 precursor | KGFR | KSAM | Keratinocyte growth factor receptor | Keratinocyte growth factor receptor 2 | VEGF-receptor 2 and Fibroblast growth factor receptor 2
Type:
Enzyme
Mol. Mass.:
92015.45
Organism:
Homo sapiens (Human)
Description:
P21802
Residue:
821
Sequence:
MVSWGRFICLVVVTMATLSLARPSFSLVEDTTLEPEEPPTKYQISQPEVYVAAPGESLEVRCLLKDAAVISWTKDGVHLGPNNRTVLIGEYLQIKGATPRDSGLYACTASRTVDSETWYFMVNVTDAISSGDDEDDTDGAEDFVSENSNNKRAPYWTNTEKMEKRLHAVPAANTVKFRCPAGGNPMPTMRWLKNGKEFKQEHRIGGYKVRNQHWSLIMESVVPSDKGNYTCVVENEYGSINHTYHLDVVERSPHRPILQAGLPANASTVVGGDVEFVCKVYSDAQPHIQWIKHVEKNGSKYGPDGLPYLKVLKAAGVNTTDKEIEVLYIRNVTFEDAGEYTCLAGNSIGISFHSAWLTVLPAPGREKEITASPDYLEIAIYCIGVFLIACMVVTVILCRMKNTTKKPDFSSQPAVHKLTKRIPLRRQVTVSAESSSSMNSNTPLVRITTRLSSTADTPMLAGVSEYELPEDPKWEFPRDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFKLLKEGHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILTLTTNEEYLDLSQPLEQYSPSYPDTRSSCSSGDDSVFSPDPMPYEPCLPQYPHINGSVKT
  
Inhibitor
Name:
BDBM287085
Synonyms:
(E)-8-(3-(4-(but-2-enoyl)piperazin-1-yl)propyl)-6-(2,6-dichloro-3,5-dimethoxyphenyl)-2-(methylamino)pyrido[2,3-d]pyrimidin-7(8H)-one | US10294223, Cpd No. 86 | US11078199, Cpd 86 | US9567334, Example 86 | US9815834, Compound 86
Type:
Small organic molecule
Emp. Form.:
C27H32Cl2N6O4
Mol. Mass.:
575.487
SMILES:
CNc1ncc2cc(-c3c(Cl)c(OC)cc(OC)c3Cl)c(=O)n(CCCN3CCN(CC3)C(=O)\C=C\C)c2n1 |(-8,-1.16,;-8,.38,;-6.67,1.15,;-6.67,2.69,;-5.33,3.46,;-4,2.69,;-2.67,3.46,;-1.33,2.69,;,3.46,;,5,;-1.33,5.77,;1.33,5.78,;1.33,7.31,;2.67,8.09,;2.67,5,;2.67,3.46,;4,2.69,;5.33,3.46,;1.33,2.69,;1.33,1.15,;-1.33,1.15,;,.38,;-2.67,.38,;-2.67,-1.16,;-1.33,-1.93,;-1.33,-3.47,;,-4.24,;,-5.78,;1.33,-6.55,;2.67,-5.78,;2.67,-4.24,;1.33,-3.47,;4,-6.55,;4,-8.09,;5.33,-5.78,;6.67,-6.55,;8,-5.78,;-4,1.15,;-5.33,.38,)|
Structure:
Search PDB for entries with ligand similarity: